These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19806285)

  • 1. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.
    Breart G; Cooper C; Meyer O; Speirs C; Deltour N; Reginster JY
    Osteoporos Int; 2010 Jul; 21(7):1181-7. PubMed ID: 19806285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England.
    Osborne V; Layton D; Perrio M; Wilton L; Shakir SA
    Drug Saf; 2010 Jul; 33(7):579-91. PubMed ID: 20553059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Martín-Merino E; Petersen I; Hawley S; Álvarez-Gutierrez A; Khalid S; Llorente-Garcia A; Delmestri A; Javaid MK; Van Staa TP; Judge A; Cooper C; Prieto-Alhambra D
    Osteoporos Int; 2018 Feb; 29(2):467-478. PubMed ID: 29199359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY
    Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2010 Feb; 21(2):339-49. PubMed ID: 19513577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD.
    Cooper C; Fox KM; Borer JS
    Osteoporos Int; 2014 Feb; 25(2):737-45. PubMed ID: 24322476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.
    Rizzoli R; Laroche M; Krieg MA; Frieling I; Thomas T; Delmas P; Felsenberg D
    Rheumatol Int; 2010 Aug; 30(10):1341-8. PubMed ID: 20512336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.
    Grosso A; Douglas I; Hingorani A; MacAllister R; Smeeth L
    Br J Clin Pharmacol; 2008 Nov; 66(5):689-94. PubMed ID: 18754840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.
    Hiligsmann M; Bruyère O; Reginster JY
    Osteoporos Int; 2010 Jan; 21(1):157-65. PubMed ID: 19350339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
    Lin TC; Lee CH; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1599-607. PubMed ID: 24606074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
    Collette J; Bruyère O; Kaufman JM; Lorenc R; Felsenberg D; Spector TD; Diaz-Curiel M; Boonen S; Reginster JY
    Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of strontium ranelate and risk of acute coronary syndrome: cohort study.
    Svanström H; Pasternak B; Hviid A
    Ann Rheum Dis; 2014 Jun; 73(6):1037-43. PubMed ID: 24651624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.
    Hiligsmann M; Bruyère O; Reginster JY
    Bone; 2010 Feb; 46(2):440-6. PubMed ID: 19716940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.
    Marquis P; Roux C; de la Loge C; Diaz-Curiel M; Cormier C; Isaia G; Badurski J; Wark J; Meunier PJ
    Osteoporos Int; 2008 Apr; 19(4):503-10. PubMed ID: 17929073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium ranelate for osteoporosis?
    Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM; Audran M; Bianchi G; Braga V; Diaz-Curiel M; Francis RM; Goemaere S; Josse R; Palacios S; Ringe JD; Felsenberg D; Boonen S
    J Clin Endocrinol Metab; 2013 Feb; 98(2):592-601. PubMed ID: 23341486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.